Eriksen JG
Eriksen JG
Eksperimental Clinical Oncology, Aarhus University Hospital
Adresse e-mail validée de oncology.au.dk
Titre
Citée par
Citée par
Année
Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck
P Lassen, JG Eriksen, S Hamilton-Dutoit, T Tramm, J Alsner, J Overgaard
J Clin Oncol 27 (12), 1992-1998, 2009
6312009
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind …
J Overgaard, JG Eriksen, M Nordsmark, J Alsner, MR Horsman
The lancet oncology 6 (10), 757-764, 2005
2552005
HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
P Lassen, JG Eriksen, S Hamilton-Dutoit, T Tramm, J Alsner, J Overgaard
Radiotherapy and Oncology 94 (1), 30-35, 2010
1982010
The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial
P Lassen, JG Eriksen, A Krogdahl, MH Therkildsen, BP Ulhøi, ...
Radiotherapy and Oncology 100 (1), 49-55, 2011
1712011
Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey
C Grau, N Defourny, J Malicki, P Dunscombe, JM Borras, M Coffey, ...
Radiotherapy and Oncology 112 (2), 155-164, 2014
1422014
Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer
P Lassen, H Primdahl, J Johansen, CA Kristensen, E Andersen, ...
Radiotherapy and Oncology 113 (3), 310-316, 2014
1332014
Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck
LJ Wirth, RI Haddad, NI Lindeman, X Zhao, JC Lee, VA Joshi, ...
Journal of Clinical Oncology 23 (28), 6976-6981, 2005
1332005
The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the …
JG Eriksen, T Steiniche, J Askaa, J Alsner, J Overgaard
International Journal of Radiation Oncology* Biology* Physics 58 (2), 561-566, 2004
1332004
Neurosurgery for trigeminal neuralgia: comparison of alcohol block, neurectomy, and radiofrequency coagulation
AB Oturai, K Jensen, J Eriksen, F Madsen
The Clinical journal of pain 12 (4), 311-315, 1996
1281996
Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000
SA Theilgaard, C Buchwald, P Ingeholm, SK Larsen, JG Eriksen, ...
Acta oto-laryngologica 123 (3), 433-439, 2003
1142003
Automatic planning of head and neck treatment plans
I Hazell, K Bzdusek, P Kumar, CR Hansen, A Bertelsen, JG Eriksen, ...
Journal of applied clinical medical physics 17 (1), 272-282, 2016
942016
The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the …
JG Eriksen, T Steiniche, J Overgaard
Radiotherapy and oncology 74 (2), 93-100, 2005
922005
Esthesioneuroblastoma: what is the optimal treatment?
JG Eriksen, Lars Bastholt, Annelise S. Krogdahl, Olfred Hansen, Karsten E ...
Acta oncologica 39 (2), 231-235, 2000
922000
Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey
Y Lievens, N Defourny, M Coffey, JM Borras, P Dunscombe, B Slotman, ...
Radiotherapy and oncology 112 (2), 178-186, 2014
892014
Differential risk assessments from five hypoxia specific assays: the basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients
M Nordsmark, JG Eriksen, V Gebski, J Alsner, MR Horsman, J Overgaard
Radiotherapy and oncology 83 (3), 389-397, 2007
892007
The updated ESTRO core curricula 2011 for clinicians, medical physicists and RTTs in radiotherapy/radiation oncology
JG Eriksen, AW Beavis, MA Coffey, JWH Leer, SM Magrini, K Benstead, ...
Radiotherapy and Oncology 103 (1), 103-108, 2012
682012
Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study
J Bentzen, K Toustrup, JG Eriksen, H Primdahl, LJ Andersen, J Overgaard
Acta oncologica 54 (7), 1001-1007, 2015
662015
Automatic treatment planning improves the clinical quality of head and neck cancer treatment plans
CR Hansen, A Bertelsen, I Hazell, R Zukauskaite, N Gyldenkerne, ...
Clinical and translational radiation oncology 1, 2-8, 2016
632016
Current role of antibody therapy in patients with metastatic colorectal cancer
P Pfeiffer, C Qvortrup, JG Eriksen
Oncogene 26 (25), 3661-3678, 2007
582007
Danish Head and Neck Cancer Study Group. Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from …
J Overgaard, JG Eriksen, M Nordsmark, J Alsner, MR Horsman
Lancet Oncol 6 (10), 757-764, 2005
582005
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20